Boston Scientific To Pay $30M In Defibrillator FCA Suit

Law360, New York (October 17, 2013, 4:36 PM ET) -- Boston Scientific Corp. will pay $30 million to settle a long-running False Claims Act suit alleging its Guidant LLC unit fleeced Medicare by submitting fraudulent bills for two lines of defective implantable defibrillators, the U.S. Department of Justice said Thursday.

The agreement builds on Guidant’s guilty plea in a related criminal case over charges that the company misled the U.S. Food and Drug Administration and health care providers in the early 2000s about the dangers of its Prizm and Renewal implantable cardioverter defibrillators, according to the...
To view the full article, register now.